Cited by 951Schizophrenia research and treatmentCardiac Health and Mental HealthDiabetes, Cardiovascular Risks, and Lipoproteins

The DOI matches its Crossref record; 150 of the 152 references it cites were found in a registry or an index.

Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC)

De Hert, M., Dekker, J.M., Wood, D., Kahl, K.G., Holt, R.I.G., Möller, H.-J.·2009·European Psychiatry

DOI 10.1016/j.eurpsy.2009.01.005

Open this paper in CoChat — free account

Abstract

People with severe mental illnesses, such as schizophrenia, depression or bipolar disorder, have worse physical health and reduced life expectancy compared to the general population. The excess cardiovascular mortality associated with schizophrenia and bipolar disorder is attributed in part to an increased risk of the modifiable coronary heart disease risk factors; obesity, smoking, diabetes, hypertension and dyslipidaemia. Antipsychotic medication and possibly other psychotropic medication like antidepressants can induce weight gain or worsen other metabolic cardiovascular risk factors. Patients may have limited access to general healthcare with less opportunity for cardiovascular risk screening and prevention than would be expected in a non-psychiatric population. The European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC) published this statement with the aim of improving the care of patients suffering from severe mental illness. The intention is to initiate cooperation and shared care between the different healthcare professionals and to increase the awareness of psychiatrists and primary care physicians caring for patients with severe mental illness to screen and treat cardiovascular risk factors and diabetes.

Integrity signals

Registry

Crossref · 10.1016/j.eurpsy.2009.01.005

Cites

150 of 150 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 retracted

RETRACTED: Obesity and physical activity: A review
Bensimhon, D., Kraus, W. E., & Donahue, M. (2006) · American Heart Journal · doi:10.1016/j.ahj.2005.03.005 · Cited by 122
Retracted
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Prevention of Type 2 Diabetes Mellitus by Changes in Lifestyle among Subjects with Impaired Glucose Tolerance
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873 · cited 1×
“- Document téléchargé le 23/06/2011 par AS OF EUROPEAN diabetes [78,131].”
Background
Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia
Lieberman, J. A., Stroup, T. S., McEvoy, J. P., Swartz, M. S., Rosenheck, R. A., Perkins, D. O., Keefe, R. S. E., Davis, S. M., Davis, C. E., Lebowitz, B. D., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051688 · Cited by 5,892
2007 Guidelines for the Management of Arterial Hypertension
Mancia, G., Backer, G. D., Dominiczak, A. F., Cífková, R., Fagard, R. H., Germanò, G., Grassi, G. M., Heagerty, A. M., Kjeldsen, S. E., Laurent, S., et al. (2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e3281fc975a · Cited by 5,870
European guidelines on cardiovascular disease prevention in clinical practice: executive summary
Graham, I., Atar, D., Borch‐Johnsen, K., Boysen, G., Burell, G. K., Cífková, R., Dallongeville, J., Backer, G. D., Ebrahim, S. B. J., Gjelsvik, B., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm316 · Cited by 3,865
Self-citation
The Cardiovascular Health Study: design and rationale.
Fried, L. P., Borhani, N. O., Enright, P., Furberg, C. D., Gardin, J. M., Kronmal, R. A., Kuller, L. H., Manolio, T. A., Mittelmark, M. B., Newman, A., et al. (1991) · Annals of Epidemiology · doi:10.1016/1047-2797(91)90005-w · Cited by 3,652
Diagnosis and Classification of diabetes mellitus
Rossi, G. (2014) · Diapedia.org eBooks · doi:10.14496/dia..20 · Cited by 3,212
International Expert Committee report on the role of the A1c assay in the diagnosis of diabetes
The International Expert Committee (2009) · Diabetes Care · doi:10.2337/dc09-9033 · Cited by 3,185
Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy.
Rozanski, A., Blumenthal, J. A., & Kaplan, J. (1999) · Circulation · doi:10.1161/01.cir.99.16.2192 · Cited by 2,846

Flagged first, then by citations

Show all 152 references

2 of the 152 references couldn’t be matched to a known paper.

Research works printed but not linked: 8

10.1176/ajp.2006.163.4.611 · DOI
Scheen, 2008, Traitement neuroleptique et troubles metabolic, Med Mal Metabol, 2, 593
Correll, 2008, Assessing and maximizing the safety and tolerability of antipsychotics used in the treatment of children and adolescents, J Clin Psychiatry, 69, 26
Citrome, 2007, Risk-Benefit Analysis of Available Treatments for Schizophrenia, Psychiatric Times, 1, 27
2008, Clinical Practice Guidelines for the prevention and management of diabetes in Canada, Can J Diabetes, 32, S1
Casey, 2004, Antipsychotic-Induced Weight Gain and Metabolic Abnormalities: Implications for Increased Mortality in Patients With Schizophrenia, J Clin Psychiatry, 65, 4
Henderson, 2005, Schizophrenia and comorbid metabolic disorders, J Clin Psychiatry, 66, 11
Nicol, 2009, Preliminary results of the MEAC study: metabolic effects of antipsychotics in children, Schizophr Bull, 35, 32

Sorted by citations

Items 701–800 of 948

Dramatic Weight Loss Following Addition of Aripiprazole to Olanzapine in a Patient With Treatment-resistant Schizophrenia: A Case Report
Boland, X., & Chhabra, P. (2019) · Journal of Psychiatric Practice · doi:10.1097/pra.0000000000000372 · Cited by 3
Mental Health Nurses' Knowledge of Clozapine
Sanjeevi, S., & Cocoman, A. M. (2020) · Issues in Mental Health Nursing · doi:10.1080/01612840.2020.1789786 · Cited by 2
Bipolar disorders, obesity, and metabolic disturbances: Mechanisms and implications
Murru, A., Anmella, G., Giménez, A., & Vieta, E. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819182-8.00022-3 · Cited by 2
Primäre Psychose und Typ-2-Diabetes
Davis-Glurich, S., Haas, B., Thume, K., & Braus, D. F. (2021) · Der Diabetologe · doi:10.1007/s11428-021-00799-9 · Cited by 2
The Biopsychosocial Model Advanced by Evolutionary Theory
Hunt, A., John‐Smith, P. S., & Abed, R. (2021) · Cambridge University Press eBooks · doi:10.1017/9781911623625.004 · Cited by 2
Physical Health of People with Mental Illness
Holt, R. I. G., Shiers, D., & Peveler, R. (2018) · Cambridge University Press eBooks · doi:10.1017/9781911623038.021 · Cited by 2
Self-citation
Syndrome métabolique et antipsychotiques atypiques : recommandations et prise en charge clinique
Solida, A., Choong, E., Lechaire, C., Eap, C. B., & Conus, P. (2011) · L information psychiatrique · doi:10.3917/inpsy.8709.0715 · Cited by 2
Practice of and services for psychosocial rehabilitation of people with schizophrenia in Belgium
Binder, M. D., Detraux, J., & Peuskens, J. (2010) · Giornale italiano di psicopatologia/Journal of psychopathology/Italian journal of psychopathology · Cited by 2
Evidence-based pharmacotherapy of schizophrenia
Leucht, S., Heres, S., Kissling, W., & Davis, J. M. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9780511910395.003 · Cited by 2
Incidence of Metabolic Syndrome in patients treated with Clozapine in a tertiary care center in central Kerala
Joseph, P. K., Kuttichira, P., & Saibunnisa Beevi, K. (2019) · Kerala Journal of Psychiatry · doi:10.30834/kjp.32.1.2019.169 · Cited by 2
Schizophrenia
Buckley, P. F., & Foster, A. E. (2014) · Springer eBooks · doi:10.1007/978-3-7091-0715-7_4 · Cited by 2
Antipsychotic Use and Risk for Hyperglycemia in Elderly Patients With DM
Binder, M. D., & Cohen, D. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.449 · Cited by 2
Why Primary Care Matters for Early Intervention in Psychiatry
Shiers, D., & Lester, H. E. (2014) · Early Intervention in Psychiatry · doi:10.1002/9781118557174.ch13 · Cited by 1
Importance of physical health in patients with schizophrenia
Höschl, C. (2010) · European Psychiatry · doi:10.1016/s0924-9338(10)71698-9 · Cited by 2
Coronary Artery Calcium in Individuals With Severe Mental Illness
Polonsky, T. S., & Miedema, M. D. (2019) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.119.008861 · Cited by 2
Depolarization of coherent backscattering
Kuzmin, V. L., Romanov, V. P., & Kuzmin, L. V. (1992) · Optics and Spectroscopy · Cited by 2
Psychiatrische und medizinische Komorbidität en bei Betroffenen mit bipolar affektiver Störung
Godemann, F., Wiegand, H. F., Wolff‐Menzler, C., Nitschke, R., Häfner, S., Pogarell, O. M., Falkai, P., Löhr, M. J., & Seemüller, F. (2014) · Nervenheilkunde · doi:10.1055/s-0038-1627757 · Cited by 1
Преваленција на метаболички синдром кај пациенти со шизофренија во Центарот за ментално здравје "Пролет", Психијатриска болница – Скопје
Исјановски, В., & Исјановски, И. (2019) · Archives of Public Health · doi:10.3889/aph.2019.2861 · Cited by 1
Doença Somática nas Pessoas com Doença Mental Grave
Martins, D. O., Rodrigues, S., Pinho, M., & Pereira, E. G. (2022) · Revista Portuguesa de Psiquiatria e Saúde Mental · doi:10.51338/rppsm.375 · Cited by 1
From Fragmentation to Integrated Care
Cabassa, L. J. (2023) · doi:10.1093/oso/9780190937300.003.0006 · Cited by 1
Comparison of the Safety and Weight Loss Efficacy of Metformin and Liraglutide in Psychiatric Outpatients at a University Hospital: A Retrospective Chart Review
Seo, M., Choi, W.-S., Woo, Y. S., & Bahk, W. (2024) · Mood and Emotion · doi:10.35986/me.2024.22.1.1 · Cited by 1
Metabolic syndrome in psychiatric disorders
Shah, A. B. (2024) · Archives of Biological Psychiatry · doi:10.25259/abp_24_2023 · Cited by 1
Consensus in Psychiatric Emergencies Using the Delphi Technique
Lee, H., Noh, J., Choi, J., Cho, H., Kim, K.-B., Seo, S., Yun, S., & Hong, E. H. (2024) · Psychiatry Investigation · doi:10.30773/pi.2024.0193 · Cited by 1
DIAMONDS—a diabetes self-management intervention for people with severe mental illness: protocol for an individually randomised controlled multicentre trial
O’Carroll, G., Brown, J. V. E., Carswell, C., Peck, C., Russell, G., Ajjan, R., Boehnke, J. R., Coventry, P. A., Hadjiconstantinou, M., Hewitt, C. E., et al. (2025) · BMJ Open · doi:10.1136/bmjopen-2024-090295 · Cited by 2
Self-citation
Risk Factors and Management Strategies for Antipsychotic-Induced Weight Gain: A Prescriptive Review for Clinicians
Stogios, N., Prasannakumar, A., Mehra, K., Hahn, M., & Agarwal, S. M. (2025) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.20250020 · Cited by 2
One-year efficacy of the LIFESTYLE intervention in improving diet, physical activity and reducing alcohol use in overweight people with severe mental illness: multicentre randomised controlled trial
Luciano, M., Catapano, P., Sampogna, G., Rocca, B. D., Vincenzo, M. D., Maj, F., D’Ambrosio, E., Rampino, A., Amore, M., Calcagno, P., et al. (2025) · BJPsych International · doi:10.1192/bji.2025.10076 · Cited by 1
Analysis of drug-drug interactions between psychiatric drugs in spontaneous adverse drug reaction reports from EudraVigilance
Dubrall, D., Christ, P., Böhme, M., Hahn, M., Schmid, M., & Scholl, C. (2026) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-04956-5 · Cited by 1
Guideline-directed Low-density Lipoprotein Cholesterol Management After Acute Coronary Syndrome in Patients With Mental Illness: a Population-based Study
Avidan, Y., Kobo, O. M., Weizman, B., Jonas, M., Hadar, D., Zafrir, B., & Kassem, S. (2026) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-026-07918-y · Cited by 1
The Challenge of Developing Person-Centred Services to Manage Comorbid Mental and Physical Illness
Gask, L. L. (2014) · Key issues in mental health (Online)/Key issues in mental health (Print) · doi:10.1159/000365600 · Cited by 1
An Evaluation of the Potential Effectiveness of a Tai Chi Program for Health Promotion Among People with Severe Mental Illness
Chapleau, A., & Dirette, D. P. (2013) · The Open Journal of Occupational Therapy · doi:10.15453/2168-6408.1036 · Cited by 1
Syndrome métabolique et antipsychotiques atypiques : recommandations et prise en charge clinique
Solida, A., Choong, E., Lechaire, C., Eap, C. B., & Conus, P. (2011) · L information psychiatrique · doi:10.1684/ipe.2011.0853 · Cited by 3
Analyse de prescription : associations d’antipsychotiques atypiques
Lagrange, F. (2011) · Le Pharmacien Hospitalier et Clinicien · doi:10.1016/j.phclin.2011.07.008 · Cited by 1
METABOLIC PARAMETERS IN A SUBSET OF PATIENTS IN THE SCOP STUDY
Binder, M. D., Mittoux, A., He, Y., & Peuskens, J. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.02.953 · Cited by 1
Interventions for smoking cessation in psychiatric settings
Čivljak, M., Bilić, P., & Milošević, M. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011722.pub2 · Cited by 1
Long-term pharmacotherapy of schizophrenic patients: Achievements, unsolved needs and future perspectives with special focus on long-acting injectable second generation antipsychotics
Möller, H. (2010) · Cited by 1
Self-citation
Understanding antipsychotic-induced weight gain and other metabolic issues
Richards, D. B., & Bressington, D. T. (2015) · British Journal of Mental Health Nursing · doi:10.12968/bjmh.2015.4.4.157 · Cited by 1
Examining the Inner Experience of Individuals with Bipolar Disorder
Kang, J. Y. (2020) · Digital Scholarship - UNLV (University of Nevada Reno) · doi:10.34917/8220116 · Cited by 1
Psychopharmacological management of schizophrenia
Castle, D. J., Tran, N., & Alderton, D. (2012) · CRC Press eBooks · doi:10.3109/9781842145357.001 · Cited by 1
BMI independently relates to glycaemia in patients with severe enduring mental illness (SMI)
Anderson, S. G., Narayanan, R. P., Radford, D., Hodgson, R. E., Binder, M. D., & Heald, A. H. (2016) · Journal of Mental Health · doi:10.1080/09638237.2016.1207233 · Cited by 1
Cardiovascular diseases in Patients with Bipolar disease: Pragmatic Management.
Jesus, C., Jesus, I., & Agius, M. A. (2016) · PubMed · Cited by 1
Promotion of Mental Health of the Elderly
Kalasic, A. M., & Pfeiffer, A. (2017) · Springer eBooks · doi:10.1007/978-3-319-59123-0_14 · Cited by 2
Antipsychotic-Related Mortality
Cohen, D. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803376-0.00015-0 · Cited by 1
Psychology, Mental Health, and Quality of Life
Snoek, F. J., Brodar, K. E., Cuddeback, G. S., Fisher, E. B., Golin, C. E., & Sokol, R. L. (2018) · Springer eBooks · doi:10.1007/978-0-387-93826-4_32 · Cited by 1
Diabetes mellitus in patients with mental disorders: Prevalence and associated factors
Owolabi, D. S., Gwaram, B. A., Femi, O. L., Umar, M. U., Umar, M. M., Musbahu, A., Shehu, A., & Isah, S. Y. (2018) · Pyramid Journal of Medicine · doi:10.4081/pjm.2018.5 · Cited by 1
A SERVICE IMPROVEMENT OPPORTUNITY FOR PHARMACIST INDEPENDENT PRESCRIBERS? A LITERATURE REVIEW EXAMINING THE RELATIONSHIP BETWEEN POOR DIABETES CONTROL AND THE CO-EXISTENCE OF MENTAL HEALTH ISSUES
Bibi, N., Morrissey, H., & Ball, P. (2019) · International Journal of Current Pharmaceutical Research · doi:10.22159/ijcpr.2019v11i4.34930 · Cited by 1
Antipsychotics and schizophrenia, and their relationship to diabetes
Whicher, C. A., Brewster, S., & Holt, R. I. G. (2019) · Practical Diabetes · doi:10.1002/pdi.2235 · Cited by 2
Self-citation
Salud y Enfermedad Mental. Del Corpus Hippocraticum a una aproximación termodinámica
Rojas-Malpica, C., de Lima-Salas, M. Á., Eblén-Zajjur, A., & Téllez-Pacheco, P. (2019) · Revista de Neuro-Psiquiatría · doi:10.20453/rnp.v82i4.3649 · Cited by 1
Analyse de prescription : associations d’antipsychotiques atypiques
Lagrange, F. (2011) · Le Pharmacien Hospitalier et Clinicien · doi:10.1016/j.phclin.2011.07.011 · Cited by 1
Medical comorbidity among psychiatric patients treated at Jimma University Medical Center, Southwest Ethiopia: Retrospective record review
Guta, M. T., Soboka, M., Feyissa, G. T., Salelew, E., & Kerebih, H. (2020) · Neurology Psychiatry and Brain Research · doi:10.1016/j.npbr.2020.09.004 · Cited by 1
The Gut Microbiome in Serious Mental Illnesses
Tzavellas, E., Logotheti, M., & Stefanis, N. C. (2021) · The microbiomes of humans, animals, plants, and the environment · doi:10.1007/978-3-030-59642-2_8 · Cited by 1
Women, men, and health
Cooper, D. D., & Tabana, H. (2021) · doi:10.1093/med/9780198816805.003.0085 · Cited by 1
Physical Comorbidities and Mood Disorders in Older Adults
Dols, A., & Sonnenberg, C. (2017) · Mental health and illness worldwide · doi:10.1007/978-981-10-2414-6_15 · Cited by 2
Interventions for smoking cessation in psychiatric settings
Čivljak, M., Bilić, P., & Milošević, M. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011722 · Cited by 1
Retracted
Nationwide Evaluation of Quality of Care Indicators for Individuals with Severe Mental Illness and Diabetes Mellitus, Following Israel’s Mental Health Reform
Barasche-Berdah, D., Ein‐Mor, E., Calderon‐Margalit, R., Rose, A. J., Krieger, M., Brammli‐Greenberg, S., Ben-Yehuda, A., Manor, O., Cohen, A. D., Bar-Ratson, E., et al. (2023) · Community Mental Health Journal · doi:10.1007/s10597-023-01178-y · Cited by 1
Barriers, Facilitators, and Experiences of Physical Exercise Programs in Outpatient Mental Health Services
López-Moral, Á., Munguía‐Izquierdo, D., & Bueno‐Antequera, J. (2023) · Advances in psychology, mental health, and behavioral studies (APMHBS) book series · doi:10.4018/978-1-6684-6040-5.ch006 · Cited by 1
Exploring the Role of Physical Exercise to Improve Cardiorespiratory Fitness and Muscular Strength Among Individuals With Severe Mental Disorder
López-Moral, Á., Munguía‐Izquierdo, D., & Bueno‐Antequera, J. (2023) · Advances in psychology, mental health, and behavioral studies (APMHBS) book series · doi:10.4018/978-1-6684-6040-5.ch008 · Cited by 2
Prescriptions of psychotropic and somatic medications among patients with severe mental disorders and healthy controls in a naturalistic study
Shafi, D. E. S., Jørgensen, K. N., Bjella, T. D., Nesvåg, R., Dieset, I., Melle, I. S., Andreassen, O. A., & Jönsson, E. G. (2024) · Nordic Journal of Psychiatry · doi:10.1080/08039488.2024.2305806 · Cited by 2
Prevalence and Major Risk Factors of Type 2 Diabetes Mellitus Among Adult Psychiatric Patients in Taif Mental Hospital in Saudi Arabia
Altuwairqi, Y. A. (2024) · SAS Journal of Medicine · doi:10.36347/sasjm.2024.v10i03.002 · Cited by 1
Disruption of Lipid Profile, Glucose Metabolism, and Leptin Levels following Citalopram Administration and High-Carbohydrate and High-Cholesterol Diet in Mice
Hammer, T., Kotolová, H., Procházka, J. H., & Karpíšek, M. (2024) · Pharmacology · doi:10.1159/000541229 · Cited by 1
Metabolische unerwünschte Arzneimittelwirkungen von Psychopharmaka
Gahr, M. (2024) · Fortschritte der Neurologie · Psychiatrie · doi:10.1055/a-2405-5087 · Cited by 1
Kardiologische Erkrankungsbilder
Seemüller, G., Seemüller, F., & von Bary, C. (2024) · Elsevier eBooks · doi:10.1016/b978-3-437-21442-4.00023-1 · Cited by 1
Concurrence of clozapine-induced diabetic ketoacidosis and neuroleptic malignant syndrome: A case report
Shin, M. H., Jeong, J. W., & Yu, T. Y. (2025) · Medicine · doi:10.1097/md.0000000000044172 · Cited by 2
Obesity Associated Disease in People with Mental Disorders: the Role of Psychotropic Medication and BMI
Kolind, M. I., Beier, C. P., Nygaard, N.-P. B., Stenager, E. N., & Juhl, C. B. (2025) · Community Mental Health Journal · doi:10.1007/s10597-025-01536-y · Cited by 1
Puesta en marcha y desarrollo de un programa de enlace de salud mental con el área del corazón.
Corral, M. I. R., Calleja, P. A., Alonso, N., Menéndez, Á., Rubio, E. L., Rodríguez, J. C., Laviana, M. J. G., Menéndez, M. C. F., & Carrio, A. M. S. (2011) · Psicologia.com · Cited by 1
Obesity in pregnancy and mental health
Howard, L. M., & Croker, H. A. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9780511782466.008 · Cited by 1
Evaluación y seguimiento metabólico del paciente con diagnóstico de esquizofrenia
Lugo, G. F. O., Gómez–Restrepo, C., Peñaranda, A. P. B., Valencia, J. G., Jaramillo, L. E., Tamayo, N., de Arenas, M. L. C. N., & Fernández, C. V. (2015) · Revista Colombiana de Psiquiatría · doi:10.1016/j.rcp.2015.05.008 · Cited by 1
Mind the body!
van Gool, R., & van Meijel, B. (2012) · Nederlands Tijdschrift voor Evidence Based Practice · doi:10.1007/s12468-012-0011-x · Cited by 1
Coronary artery disease in adults with schizophrenia: Anatomy, treatment and outcomes
Todd, R. A., Lewin, A. M., Bresee, L. C., Southern, D. A., & Rabi, D. M. (2014) · IJC Heart & Vessels · doi:10.1016/j.ijchv.2014.06.009 · Cited by 1
Efectos adversos metabólicos y endocrinos de los antipsicóticos de segunda generación en niños y adolescentes: una revisión sistemática de ensayos aleatorizados, controlados con placebo y guías de práctica clínica
Hert, M. A. F. D., Dobbelaere, M., Sheridan, E. M., Cohen, D., & Correll, C. U. (2011) · Psiquiatría Biológica · doi:10.1016/j.psiq.2011.10.002 · Cited by 1
Clinical Assessment of Older Adults with Bipolar Disorder
Dols, A., Chen, P., Jurdi, R. K. A., & Sajatovic, M. (2017) · Springer eBooks · doi:10.1007/978-3-319-48912-4_2 · Cited by 1
Metabolic Side Effects of Antipsychotic Medication: An Overview
Lee, J. S. (2019) · 신경정신의학 · doi:10.4306/jknpa.2019.58.1.18 · Cited by 3
The impact of increasing general hospital admissions on Consultation–Liaison Psychiatry
Holmes, A., Handrinos, D., Jones, S., & Huang, B. (2020) · Australasian Psychiatry · doi:10.1177/1039856220926941 · Cited by 1
Are metabolic disorders part of a severe mental illness? Historical and current perspective
Łopuszańska, U. (2020) · Journal of Education Health and Sport · doi:10.12775/jehs.2020.10.10.010 · Cited by 1
Effect of atypical antipsychotics on blood glucose levels and HbA1c in patients of schizophrenia and bipolar disorder.
Bughio, A. H., Ansari, S., Kumar, R., Sheikh, M. H., & Devrajani, T. (2021) · The Professional Medical Journal · doi:10.29309/tpmj/2021.28.02.5189 · Cited by 1
The RAS-24: Development and validation of an adherence-to-medication scale for severe mental illness patients
Ralat, S. I., & Rodríguez-Gómez, J. (2023) · Journal of Clinical and Translational Science · doi:10.1017/cts.2023.527 · Cited by 1
Maladie cardiovasculaire et diabète chez les personnes atteintes d’une maladie mentale sévère
Scheen, A. J., Gillain, B., & Hert, M. A. F. D. (2010) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(10)70049-3 · Cited by 1
Effects of Exercise in Adults with Physical and Cognitive Disabilities - A Meta-Analysis
Chen, M. (2011) · Figshare · Cited by 1
How Should Secondary Causes of Diabetes Be Excluded?
Griffin, T. P., O’Loughlin, A., & Dinneen, S. F. (2021) · Wiley eBooks · doi:10.1002/9781119603207.ch4 · Cited by 2
The Impact of Cardiometabolic Risk in Patients with Severe Mental Illness: From Evidence to Clinical Management
Di, G., & Calò, S. (2011) · InTech eBooks · doi:10.5772/26001
Pharmakotherapie der Depression bei Menschen mit Diabetes
Kahl, K. G., Lampen-Imkamp, S., Göllner, K., Liersch, J., Claaßen, B., Wilkening, A., Schik, G., & Peschel, T. (2010) · Der Diabetologe · doi:10.1007/s11428-009-0534-6 · Cited by 1
Self-citation
Editorial for Nordic Journal of Psychiatry
Hert, M. A. F. D. (2010) · Nordic Journal of Psychiatry · doi:10.3109/08039488.2010.520206 · Cited by 1
Cardiovascular risk and disease among people with mental health disorders in Canada
Goldie, C. (2014) · cIRcle (University of British Columbia) · doi:10.14288/1.0166832 · Cited by 1
Drug‐Induced Diabetes
Ponte, C. D., & Dang, D. K. (2016) · Wiley eBooks · doi:10.1002/9781118924853.ch19 · Cited by 1
Large-scale differential gene expression analysis identifies genes associated with Bipolar Disorder in post-mortem brainPreprint
Omar, M. N., Youssef, M., & Abdellatif, M. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/770529 · Cited by 1
SSRIs as Risk Reduction for Cardiovascular Disease in Patients with SchizophreniaPreprint
Bellon, A., & Nguyen, K. (2020) · Preprints.org · doi:10.20944/preprints202010.0163.v1 · Cited by 1
Meeting the physical health needs of people with serious mental illness in primary care
Bosanquet, K. (2020) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York) · Cited by 1
Treatment of hypertension in women and men
Ljungman, C. E. A. (2014) · Gothenburg University Publications Electronic Archive (Gothenburg University)
Depression and Diabetes Prevention
Hermanns, N. (2013) · Wiley eBooks · doi:10.1002/9781118661321.ch5
Perfil de fatores de risco para doença cardiovascular em amostra de estudo epidemiológico populacional de morbidade psiquiátrica: estudo São Paulo Megacity
de Lima, D. B. (2011) · doi:10.11606/t.5.2011.tde-07122011-123530
Bipolar Disorder and Reducing Risk for Cardiovascular Disease
Kilbourne, A. M., & Goodrich, D. E. (2011) · Wiley eBooks · doi:10.1002/9780470975138.ch10
Necesidades de apoyo en personas con enfermedad mental grave y carga familiar en cuidadores primarios de México
Ortiz, M. C. (2010) · Gredos (University of Salamanca) · doi:10.14201/gredos.83299
Bedeutung genetischer Polymorphismen in den Genen des Transportproteins SLC6A14, des Leptinrezeptors, des Adiponektins und des Adiponektin-Rezeptors für das Risiko, unter Antipsychotikatherapie Übergewicht zu erleiden
Torno, E.-C. (2012) · doi:10.53846/goediss-1179
Comparing tolerability profile of second generation antipsychotics in schizophrenia and affective disorders : a meta-analysis
Moteshafi, H. (2011) · doi:10.71781/27694
5 – Pharmacologie de la schizophrénie
Pignon, B., Tebeka, S., Schürhoff, F., & Szöke, A. (2015) · doi:10.1016/b978-2-294-73908-8.00005-7
Auswirkungen stationärer Aufnahmen auf das Rauchverhalten psychiatrischer und somatischer Patienten
Silberbauer, C., & Grünbacher, E. (2014) · Neuropsychiatrie · doi:10.1007/s40211-014-0102-1
2960 – Importance of Physical Health in The Long-Term Management of Bipolar I Disorders
Hert, M. D. (2013) · European Psychiatry · doi:10.1016/s0924-9338(13)77491-1
Attention to Medical Conditions During Mental Health Clinic Visits
Miller, M. J. (2013) · Clinical Schizophrenia & Related Psychoses · doi:10.3371/csrp.mi.012513
Investigation of genetic variation contributing to antipsychotic treatment response in a South African first episode schizophrenia cohort.
Drögemöller, B. I. (2013) · SUNScholar (Stellenbosch University)
Sex Steroids and Gene Variants in Bipolar Disorder
Johansson, A. G. M. (2012) · Figshare
Korean Medication Algorithm for Bipolar Disorder 2014: Safety and Tolerability
Sohn, I., Kim, M.-D., Lee, J. G., Yoon, B. H., Jeong, J. H., Shim, S. H., Woo, Y. S., Seo, J. S., Shin, Y. C., Min, K. J., et al. (2014) · 대한정신약물학회지

Authors: De Hert, M., Dekker, J. M., Wood, D., Kahl, K. G., Holt, R. I. G., & Möller, H.-J.
Affiliations: KU Leuven (BE)
Imperial College London (GB)
Medizinische Hochschule Hannover (DE)
University of Southampton (GB)
Ludwig-Maximilians-Universität München (DE)
ORCID: Wood, D.
Holt, R.I.G.
Venue: European Psychiatry
Publisher: Cambridge University Press (CUP)
Published: 2009-09
Volume: 24
Issue: 6
Pages: 412-424
ISSN: 0924-9338 (ISSN-L)
1778-3585
DOI: 10.1016/j.eurpsy.2009.01.005
OpenAlex: W2154493342
Cited by: 951
References: 152
Citations by year: 2026: 27 · 2025: 32 · 2024: 37 · 2023: 61 · 2022: 42 · 2021: 64 · 2020: 59 · 2019: 62 · 2018: 46 · 2017: 44 · 2016: 69 · 2015: 63 · 2014: 71 · 2013: 66 · 2012: 65
FWCI: 42.54
Type: journal article
Language: en
Open access: closed
Licence: www.cambridge.org/core/terms (unspecified, 3880 d)
Locations: European Psychiatry (publishedVersion)
PubMed (publishedVersion)
Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam) (submittedVersion)
Lirias (submittedVersion)
Pure Amsterdam UMC (submittedVersion)
Data Archiving and Networked Services (DANS) (submittedVersion)
Funders: Bristol-Myers Squibb
European Society of Cardiology
European Association for the Study of Diabetes
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Health and Mental Health
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords: severe mental illness, cardiovascular disease, diabetes mellitus, schizophrenia, bipolar disorder, depression, cardiovascular risk factors, antipsychotic-induced weight gain, psychotropic drugs, cardiovascular risk screening, cardiovascular disease prevention, shared care, life expectancy, coronary artery disease
MeSH terms: Bipolar Disorder, Cardiovascular Diseases, Cause of Death, Cross-Sectional Studies, Major Depressive Disorder, Diabetes Mellitus, Follow-Up Studies, Humans, Mass Screening, Obesity, Psychotic Disorders, Psychotropic Drugs, Risk Factors, Schizophrenia, Societies, Medical, Comorbidity, Practice Guidelines as Topic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC)

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks